Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

ADAMTSL4 – Ectopia lentis et pupillae

ADAMTSL4 encodes an ADAMTS-like secreted glycoprotein essential for fibrillin microfibril biogenesis in the eye. Biallelic loss-of-function variants in ADAMTSL4 cause autosomal recessive ectopia lentis et pupillae (ELeP), characterized by lens subluxation, pupillary dysfunction, and axial elongation.

In a large Dutch pedigree, seven of eight affected individuals harbored homozygous nonsense (p.Gln752Ter) or compound heterozygous frameshift (c.2270dup (p.Gly758fs)) variants in ADAMTSL4, confirming AR inheritance by segregation in unaffected parents (PMID:23426735). A second family with three siblings exhibited compound heterozygous frameshift alleles (p.Ser264LeufsTer37/p.Gly757ValfsTer62) linked to ELeP over 12 years of follow-up (PMID:36089008). A pseudodominant pedigree described a 4-year-old proband and asymptomatic homozygous parent, highlighting variable expressivity despite a shared founder allele (PMID:35218299). In total, 11 unrelated probands across three families have been reported with biallelic ADAMTSL4 truncating variants.

Segregation analysis demonstrates complete concordance of biallelic LoF alleles with disease status; heterozygous carriers are asymptomatic, supporting a loss-of-function mechanism. No pathogenic missense or deep-intronic alleles have been recurrently reported.

Functional studies confirm ADAMTSL4 expression in human iris, ciliary body, and choroid but not neural retina, suggesting a role in zonule fiber anchorage (PMID:23846871). Adamtsl4 knockout mice recapitulate lens subluxation, pupillary defects, and increased axial length, mirroring human ELeP (PMID:26405179). In vitro mini-gene assays of the recurrent intronic variant c.2177+4A>G demonstrate exon-skipping, premature termination codons, and NMD, reducing ADAMTSL4 protein levels (PMID:39278391).

No conflicting reports have been published. The collective genetic and experimental data meet criteria for a Definitive gene–disease association: multiple pedigrees over >10 years, robust segregation, and concordant in vivo and in vitro functional evidence.

Key Take-home: Biallelic ADAMTSL4 loss-of-function variants reliably cause autosomal recessive Ectopia lentis et pupillae; genetic testing of ADAMTSL4 informs diagnosis, family counseling, and potential early ocular interventions.

References

  • Experimental eye research • 2022 • Correlation between novel compound heterozygous ADAMTSL4 variants and primary phenotypes of ectopia lentis et pupillae. PMID:36089008
  • American journal of medical genetics. Part A • 2022 • ADAMTSL4-related ectopia lentis: A case of pseudodominance with an asymptomatic parent. PMID:35218299
  • The British journal of ophthalmology • 2013 • Ectopia lentis et pupillae in four generations caused by novel mutations in the ADAMTSL4 gene. PMID:23426735
  • The British journal of ophthalmology • 2013 • Gene expression and protein distribution of ADAMTSL-4 in human iris, choroid and retina. PMID:23846871
  • Human molecular genetics • 2015 • Disruption of murine Adamtsl4 results in zonular fiber detachment from the lens and in retinal pigment epithelium dedifferentiation. PMID:26405179
  • Experimental eye research • 2024 • Mutations in ADAMTSL4 cause a unique form of autosomal-recessive congenital ectopia lentis. PMID:39278391

Evidence Based Scoring (AI generated)

Gene–Disease Association

Definitive

11 probands across three unrelated pedigrees over >10 years, autosomal recessive segregation, concordant functional data

Genetic Evidence

Strong

11 unrelated probands with biallelic truncating variants and perfect segregation in multiple families

Functional Evidence

Strong

Ocular expression studies, mouse knockout recapitulating phenotype, in vitro splicing assays confirming NMD